Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (Q34556870)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study |
scientific article |
Statements
1 reference
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (English)
1 reference
Stephan Rössner
1 reference
Luc F Van Gaal
1 reference
Aila M Rissanen
1 reference
André J Scheen
1 reference
Olivier Ziegler
1 reference
RIO-Europe Study Group
1 reference
Identifiers
1 reference